Brief: ChemoCentryx Reports Q1 2022 Results

Churchill Capital XI

05/05/2022 23:51

May 5 (Reuters) - ChemoCentryx Inc  CCXI.O :
    * CHEMOCENTRYX REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
RECENT HIGHLIGHTS
    * CASH, CASH EQUIVALENTS AND INVESTMENTS TOTALED
APPROXIMATELY
$371.8 MILLION AS OF MARCH 31, 2022
    * QTRLY BASIC AND DILUTED NET LOSS PER COMMON SHARE $0.55
    * Q1 EARNINGS PER SHARE VIEW $-0.31 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4JmZVG 
Further company coverage:  CCXI.O 

 ((Reuters.Briefs@thomsonreuters.com;))